After a long period of high growth, lower-than-expected demand from Chinese clinics and higher competition in the Americas resulted in negative sales growth in the media business unit. Optimisations in the product portfolio and continued high cost control resulted in a higher profitability than we had forecasted, reaching an impressive EBITDA margin of 40 percent.